MALLINCKRODT PHARMACEUTICALS LIMITED

Company number 09780382

Date	Type	Description	View / Download
28 Feb 2019	SH19	Statement of capital on 28 February 2019 USD 100,104	(3 pages)
28 Feb 2019	CAP-SS	Solvency Statement dated 28/02/19	(1 page)
28 Feb 2019	RESOLUTIONS	Resolutions RES13 ‐ Cancellation of share premium 28/02/2019 RES06 ‐ Resolution of reduction in issued share capital	(1 page)
18 Jan 2019	CH01	Director's details changed for Ms Stephanie Dorn Miller on 1 August 2018	(2 pages)
22 Oct 2018	SH01	Statement of capital following an allotment of shares on 28 September 2018 USD 100,104	(3 pages)
08 Oct 2018	CS01	Confirmation statement made on 15 September 2018 with updates	(4 pages)
04 Oct 2018	PSC05	Change of details for Mallinckrodt Uk Ltd as a person with significant control on 6 April 2016	(2 pages)
13 Aug 2018	AA	Full accounts made up to 29 December 2017	(27 pages)
22 May 2018	AP01	Appointment of Mr Josh Schafer as a director on 15 May 2018	(2 pages)
03 May 2018	TM01	Termination of appointment of Gary Phillips as a director on 20 April 2018	(1 page)
09 Mar 2018	AP01	Appointment of Ms Stephanie Dorn Miller as a director on 1 March 2018	(2 pages)
10 Jan 2018	TM01	Termination of appointment of Frank Scholz as a director on 29 December 2017	(1 page)
12 Dec 2017	AP03	Appointment of Stephanie Dorn Miller as a secretary on 28 November 2017	(2 pages)
04 Oct 2017	CS01	Confirmation statement made on 15 September 2017 with updates	(4 pages)
04 Oct 2017	PSC05	Change of details for Mallinckrodt Uk Ltd as a person with significant control on 14 February 2017	(2 pages)
28 Sep 2017	CH01	Director's details changed for Mr Gary Phillips on 1 July 2017	(2 pages)
28 Sep 2017	CH01	Director's details changed for Mr Frank Scholz on 1 July 2017	(2 pages)
27 Sep 2017	CH01	Director's details changed for Mr Mark Trudeau on 1 July 2017	(2 pages)
14 Sep 2017	CH01	Director's details changed for Mr Mark Trudeau on 12 June 2017	(2 pages)
22 Jun 2017	AA	Full accounts made up to 30 September 2016	(18 pages)
09 Apr 2017	SH01	Statement of capital following an allotment of shares on 28 February 2017 USD 104.00	(4 pages)
14 Feb 2017	AD01	Registered office address changed from Perth House Millennium Way Chesterfield Derbyshire S41 8nd United Kingdom to 3 Lotus Park the Causeway Staines upon Thames TW18 3AG on 14 February 2017	(1 page)
08 Feb 2017	AA01	Current accounting period extended from 30 September 2017 to 31 December 2017	(3 pages)
30 Sep 2016	AD03	Register(s) moved to registered inspection location 5th Floor 6 st. Andrew Street London EC4A 3AE	(1 page)
29 Sep 2016	CS01	Confirmation statement made on 15 September 2016 with updates	(6 pages)

Previous

• 1
• 2
• 3
• 4
• 5
• 6

Next